|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ushijima K: Current status of gynecologic
cancer in Japan. J Gynecol Oncol. 20:67–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takahashi A, Kimura F, Yamanaka A,
Takebayashi A, Kita N, Takahashi K and Murakami T: Metformin
impairs growth of endometrial cancer cells via cell cycle arrest
and concomitant autophagy and apoptosis. Cancer Cell Int.
14:532014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burke WM, Orr J, Leitao M, Salom E, Gehrig
P, Olawaiye AB, Brewer M, Boruta D and Herzog TJ: Endometrial
cancer: a review and current management strategies: part II.
Gynecol Oncol. 134:393–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu S and Li X: Autophagy inhibition
enhances sensitivity of endometrial carcinoma cells to paclitaxel.
Int J Oncol. 46:2399–2408. 2015.PubMed/NCBI
|
|
6
|
Wilson TR, Longley DB and Johnston PG:
Chemoresistance in solid tumours. Ann Oncol (Suppl). 10:x315–x324.
2006. View Article : Google Scholar
|
|
7
|
Ayers D and Nasti A: Utilisation of
nanoparticle technology in cancer chemoresistance. J Drug Deliv.
2012:2656912012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carvalho MJ, Laranjo M, Abrantes AM,
Torgal I, Botelho MF and Oliveira CF: Clinical translation for
endometrial cancer stem cells hypothesis. Cancer Metastasis Rev.
34:401–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Friel AM, Sergent PA, Patnaude C, Szotek
PP, Oliva E, Scadden DT, Seiden MV, Foster R and Rueda BR:
Functional analyses of the cancer stem cell-like properties of
human endometrial tumor initiating cells. Cell Cycle. 7:242–249.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kato K, Takao T, Kuboyama A, Tanaka Y,
Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K, et al:
Endometrial cancer side-population cells show prominent migration
and have a potential to differentiate into the mesenchymal cell
lineage. Am J Pathol. 176:381–392. 2010. View Article : Google Scholar :
|
|
12
|
Singh S, Brocker C, Koppaka V, Chen Y,
Jackson BC, Matsumoto A, Thompson DC and Vasiliou V: Aldehyde
dehydrogenases in cellular responses to oxidative/electrophilic
stress. Free Radic Biol Med. 56:89–101. 2013. View Article : Google Scholar :
|
|
13
|
Tang DG: Understanding cancer stem cell
heterogeneity and plasticity. Cell Res. 22:457–472. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cojoc M, Mäbert K, Muders MH and Dubrovska
A: A role for cancer stem cells in therapy resistance: Cellular and
molecular mechanisms. Semin Cancer Biol. 31:16–27. 2015. View Article : Google Scholar
|
|
15
|
Fukuda T, Oda K, Wada-Hiraike O, Sone K,
Inaba K, Ikeda Y, Miyasaka A, Kashiyama T, Tanikawa M, Arimoto T,
et al: The anti-malarial chloroquine suppresses proliferation and
overcomes cisplatin resistance of endometrial cancer cells via
autophagy inhibition. Gynecol Oncol. 137:538–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ran X, Yang J, Liu C, Zhou P, Xiao L and
Zhang K: MiR-218 inhibits HMGB1-mediated autophagy in endometrial
carcinoma cells during chemotherapy. Int J Clin Exp Pathol.
8:6617–6626. 2015.PubMed/NCBI
|
|
17
|
Lei Y, Zhang D, Yu J, Dong H, Zhang J and
Yang S: Targeting autophagy in cancer stem cells as an anticancer
therapy. Cancer Lett. 393:33–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharif T, Martell E, Dai C, Kennedy BE,
Murphy P, Clements DR, Kim Y, Lee PW and Gujar SA: Autophagic
homeostasis is required for the pluripotency of cancer stem cells.
Autophagy. 13:264–284. 2017. View Article : Google Scholar
|
|
19
|
Sun R, Shen S, Zhang YJ, Xu CF, Cao ZT,
Wen LP and Wang J: Nanoparticle-facilitated autophagy inhibition
promotes the efficacy of chemotherapeutics against breast cancer
stem cells. Biomaterials. 103:44–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pellegrini P, Dyczynski M, Sbrana FV,
Karlgren M, Buoncervello M, Hägg-Olofsson M, Ma R, Hartman J,
Bajalica-Lagercrantz S, Grander D, et al: Tumor acidosis enhances
cytotoxic effects and autophagy inhibition by salinomycin on cancer
cell lines and cancer stem cells. Oncotarget. 7:35703–35723.
2016.PubMed/NCBI
|
|
21
|
Song YJ, Zhang SS, Guo XL, Sun K, Han ZP,
Li R, Zhao QD, Deng WJ, Xie XQ, Zhang JW, et al: Autophagy
contributes to the survival of CD133+ liver cancer stem
cells in the hypoxic and nutrient-deprived tumor microenvironment.
Cancer Lett. 339:70–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang HZ, Ma Y, Zhou Y, Xu LM, Chen XJ,
Ding WB and Zou HB: Autophagy contributes to the enrichment and
survival of colorectal cancer stem cells under oxaliplatin
treatment. Cancer Lett. 361:128–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berardi DE, Flumian C, Rodriguez CE,
Bessone MI, Cirigliano SM, Joffé ED, Fiszman GL, Urtreger AJ and
Todaro LB: PKCδ inhibition impairs mammary cancer proliferative
capacity but selects cancer stem cells, involving autophagy. J Cell
Biochem. 117:730–740. 2016. View Article : Google Scholar
|
|
24
|
Liang DH, Choi DS, Ensor JE, Kaipparettu
BA, Bass BL and Chang JC: The autophagy inhibitor chloroquine
targets cancer stem cells in triple-negative breast cancer by
inducing mitochondrial damage and impairing DNA break repair.
Cancer Lett. 376:249–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bellodi C, Lidonnici MR, Hamilton A,
Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi
T, Yacobi R, et al: Targeting autophagy potentiates tyrosine kinase
inhibitor-induced cell death in Philadelphia chromosome-positive
cells, including primary CML stem cells. J Clin Invest.
119:1109–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang H, Gomez-Manzano C, Aoki H, Alonso
MM, Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, et
al: Examination of the therapeutic potential of Delta-24-RGD in
brain tumor stem cells: Role of autophagic cell death. J Natl
Cancer Inst. 99:1410–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ojha R, Bhattacharyya S and Singh SK:
Autophagy in cancer stem cells: A potential link between
chemoresistance, recurrence, and metastasis. Biores Open Access.
4:97–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu H, Wang D, Liu Y, Su Z, Zhang L, Chen
F, Zhou Y, Wu Y, Yu M, Zhang Z, et al: Role of the
hypoxia-inducible factor-1 alpha induced autophagy in the
conversion of non-stem pancreatic cancer cells into
CD133+ pancreatic cancer stem-like cells. Cancer Cell
Int. 13:1192013. View Article : Google Scholar
|
|
29
|
Chen Z, Che Q, He X, Wang F, Wang H, Zhu
M, Sun J and Wan X: Stem cell protein Piwil1 endowed endometrial
cancer cells with stem-like properties via inducing
epithelial-mesenchymal transition. BMC Cancer. 15:8112015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ciavardelli D, Rossi C, Barcaroli D, Volpe
S, Consalvo A, Zucchelli M, De Cola A, Scavo E, Carollo R,
D'Agostino D, et al: Breast cancer stem cells rely on fermentative
glycolysis and are sensitive to 2-deoxyglucose treatment. Cell
Death Dis. 5:e13362014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van der Zee M, Sacchetti A, Cansoy M,
Joosten R, Teeuwssen M, Heijmans-Antonissen C, Ewing-Graham PC,
Burger CW, Blok LJ and Fodde R: IL6/JAK1/STAT3 signaling blockade
in endometrial cancer affects the ALDHhi/CD126+
stem-like component and reduces tumor burden. Cancer Res.
75:3608–3622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang L and Lai D: Ovarian cancer stem
cells enrichment. Methods Mol Biol. 1049:337–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma
W, Zhang Y, Li C and Zhang S: Spheres derived from the human
SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem
cells. Cancer Lett. 299:150–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li
MZ, Shi L, Zeng MS and Song LB: Centromere protein H is a novel
prognostic marker for human nonsmall cell lung cancer progression
and overall patient survival. Cancer. 115:1507–1517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Elbasateeny SS, Salem AA, Abdelsalam WA
and Salem RA: Immunohistochemical expression of cancer stem cell
related markers CD44 and CD133 in endometrial cancer. Pathol Res
Pract. 212:10–16. 2016. View Article : Google Scholar
|
|
36
|
Kato K: Endometrial cancer stem cells: A
new target for cancer therapy. Anticancer Res. 32:2283–2293.
2012.PubMed/NCBI
|
|
37
|
Kyo S and Kato K: Endometrial cancer stem
cell as a potential therapeutic target. Semin Reprod Med.
33:341–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao Y, Liu T and Huang Y: MicroRNA-134
suppresses endometrial cancer stem cells by targeting POGLUT1 and
Notch pathway proteins. FEBS Lett. 589:207–214. 2015. View Article : Google Scholar
|
|
39
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gómez-López S, Lerner RG and Petritsch C:
Asymmetric cell division of stem and progenitor cells during
homeostasis and cancer. Cell Mol Life Sci. 71:575–597. 2014.
View Article : Google Scholar :
|
|
42
|
Gehrig PA and Bae-Jump VL: Promising novel
therapies for the treatment of endometrial cancer. Gynecol Oncol.
116:187–194. 2010. View Article : Google Scholar
|
|
43
|
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang
H and Wan X: MiR-125b promotes proliferation and migration of type
II endometrial carcinoma cells through targeting TP53INP1 tumor
suppressor in vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nagelkerke A, Sweep FC, Geurts-Moespot A,
Bussink J and Span PN: Therapeutic targeting of autophagy in
cancer. Part I: Molecular pathways controlling autophagy. Semin
Cancer Biol. 31:89–98. 2015. View Article : Google Scholar
|
|
46
|
Colak S and Medema JP: Cancer stem cells -
important players in tumor therapy resistance. FEBS J.
281:4779–4791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Konopleva M, Zhao S, Hu W, Jiang S, Snell
V, Weidner D, Jackson CE, Zhang X, Champlin R, Estey E, et al: The
anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and
contribute to chemoresistance of non-proliferating leukaemic
CD34+ cells. Br J Haematol. 118:521–534. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Madjd Z, Mehrjerdi AZ, Sharifi AM,
Molanaei S, Shahzadi SZ and Asadi-Lari M: CD44+ cancer
cells express higher levels of the anti-apoptotic protein Bcl-2 in
breast tumours. Cancer Immun. 9:42009.
|
|
49
|
Wilson BJ, Schatton T, Zhan Q, Gasser M,
Ma J, Saab KR, Schanche R, Waaga-Gasser AM, Gold JS, Huang Q, et
al: ABCB5 identifies a therapy-refractory tumor cell population in
colorectal cancer patients. Cancer Res. 71:5307–5316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gao MQ, Choi YP, Kang S, Youn JH and Cho
NH: CD24+ cells from hierarchically organized ovarian
cancer are enriched in cancer stem cells. Oncogene. 29:2672–2680.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Deng L, Broaddus RR, McCampbell A, Shipley
GL, Loose DS, Stancel GM, Pickar JH and Davies PJ: Identification
of a novel estrogen-regulated gene, EIG121, induced by hormone
replacement therapy and differentially expressed in type I and type
II endometrial cancer. Clin Cancer Res. 11:8258–8264. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Deng L, Feng J and Broaddus RR: The novel
estrogen-induced gene EIG121 regulates autophagy and promotes cell
survival under stress. Cell Death Dis. 1:e322010. View Article : Google Scholar : PubMed/NCBI
|
